The compound affects both fat metabolism and muscle health, so its useful for researchers studying the relationship between these systems
Under the Human Medicines Regulations 2012, selling or supplying either compound with therapeutic claims in the UK without a Marketing Authorisation is illegal
Oral dosing ranges discussed in research community use Phase Weeks 12 (start low) Daily dose 50 mg once daily Notes Morning dosing is the pattern most often reported
all helping to lower inflammation levels over time
[5] The primary contraindication for hydroxocobalamin injection is a known hypersensitivity to hydroxocobalamin, cobalt, or any component of the formulation
These products are not intended to diagnose, treat, cure, or preventany disease